论文部分内容阅读
目的:小剂量雌激素治疗绝经后妇女骨质疏松症的临床疗效。方法:2011年10月~2012年10月期间,我院诊治的84例绝经后妇女骨质疏松症患者,根据随机数字法,将其分为对照组(钙剂)和观察组(小剂量雌激素),每组各42例,治疗6个月,对2组临床疗效、骨密度、不良反应,进行观察和比较。结果:与对照组相比,观察组总有效率明显升高,骨密度明显升高,不良反应发生率显著降低,P<0.05,差异有统计学意义。结论:对于绝经后妇女骨质疏松症患者,小剂量雌激素治疗的疗效显著,明显改善患者的预后质量,值得临床广泛推广。
OBJECTIVE: To evaluate the clinical efficacy of low-dose estrogen in the treatment of postmenopausal women with osteoporosis. Methods: From October 2011 to October 2012, 84 cases of postmenopausal women with osteoporosis diagnosed and treated in our hospital were divided into control group (calcium group) and observation group (low dose group) according to random number method Hormones), 42 cases in each group, for 6 months. The clinical efficacy, bone mineral density and adverse reactions in the two groups were observed and compared. Results: Compared with the control group, the total effective rate in the observation group was significantly increased, bone mineral density was significantly increased, the incidence of adverse reactions was significantly reduced, P <0.05, the difference was statistically significant. Conclusion: For patients with postmenopausal osteoporosis, the efficacy of low-dose estrogen treatment is significant, and the quality of prognosis of patients with osteoporosis is significantly improved. Therefore, it is worth widely clinical promotion.